TDC
NXTM

Thompson Davis & Co’s NxStage Medical Inc. NXTM Stock Holding History

Thompson Davis & Co’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$3K Buy
+125
New +$3.52K 0.01% 650
2017
Q3 		– Sell
-125
Closed -$3K – 1253
2017
Q2 		$3K Sell
125
-625
-83% -$15.5K ﹤0.01% 963
2017
Q1 		$20K Hold
750
– – 0.03% 500
2016
Q4 		$20K Hold
750
– – 0.03% 506
2016
Q3 		$19K Buy
+750
New +$17.5K 0.03% 503
2016
Q2 		– Sell
-8,875
Closed -$133K – 1229
2016
Q1 		$133K Sell
8,875
-2,950
-25% -$49.4K 0.2% 127
2015
Q4 		$259K Buy
11,825
+6,575
+125% +$123K 0.37% 68
2015
Q3 		$83K Buy
5,250
+5,000
+2,000% +$80.2K 0.12% 180
2015
Q2 		$4K Sell
250
-23,975
-99% -$406K ﹤0.01% 975
2015
Q1 		$419K Sell
24,225
-3,350
-12% -$59.2K 0.5% 32
2014
Q4 		$494K Buy
+27,575
New +$444K 0.57% 33

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Thompson Davis & Co's NXTM Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in NxStage Medical Inc. (NXTM) in Q3 2018: 125 shares worth $3K. The stake represents 0.01% of the portfolio and ranks #650 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in NXTM as recently as Q2 2017.

Thompson Davis & Co first reported a position in NXTM in Q4 2014 and has held it in 11 quarters since. The position peaked at $494K in Q4 2014. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Thompson Davis & Co held 125 shares of NxStage Medical Inc. worth $3K as of Q3 2018.
  • NxStage Medical Inc. was a new Thompson Davis & Co position in Q3 2018.
  • NxStage Medical Inc. made up 0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #650 holding.
  • Thompson Davis & Co first reported a position in NxStage Medical Inc. in Q4 2014 and has held it in 11 quarters since.
  • Thompson Davis & Co's NxStage Medical Inc. position peaked at $494K in Q4 2014.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.